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Abstract
Dietary intake of whole grains reduces the incidence of chronic diseases such as obesity, diabetes, cardiovascular disease, and cancer. In an earlier
study, we showed that Panicum miliaceum L. extract (PME) exhibited the highest anti-lipogenic activity in 3T3-L1 cells among extracts of nine 
different cereal grains tested. In this study, we hypothesized that PME in the diet would lead to weight loss and augmentation of hyperlipidemia 
by regulating fatty acid metabolism. PME was fed to ob/ob mice at 0%, 0.5%, or 1% (w/w) for 4 weeks. After the experimental period,  body
weight changes, blood serum and lipid profiles, hepatic fatty acid metabolism-related gene expression, and white adipose tissue (WAT) fatty acid
composition were determined. We found that the 1% PME diet, but not the 0.5%, effectively decreased body weight, liver weight, and blood triglyceride
and total cholesterol levels (P< 0.05) compared to obese ob/ob mice on a normal diet. Hepatic lipogenic-related gene (PPARα, L-FABP, FAS,
and SCD1) expression decreased, whereas lipolysis-related gene (CPT1) expression increased in animals fed the 1% PME diet (P<0 . 0 5 ) .  L o n g  
chain fatty acid content and the ratio of C18:1/C18:0 fatty acids decreased significantly in adipose tissue of animals fed the 1% PME diet (P <
0.05). Serum inflammatory mediators also decreased significantly in animals fed the 1% PME diet compared to those of the ob/ob control group 
(P< 0.05). These results suggest that PME is useful in the chemoprevention or treatment of obesity and obesity-related disorders.
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Introduction3)
Obesity is characterized by excess body fat accumulation, in 
which there is a shift in the homeostatic balance between cellular 
lipogenic and lipolytic activities [1]. The liver plays an important 
role in various aspects of lipid metabolism and fat accumulation. 
Because fatty liver is closely associated with obesity-related 
physiological features, including hyperlipidemia, hyperglycemia, 
and hepatic lipid accumulation [2], hepatic triglyceride (TG) 
synthesis is an important factor in the development of obesity. 
Fatty acids are key substrates for TG synthesis. Among several 
fatty acids, palmitoleate (C16:1) and oleate (C18:1) are considered 
major substrates for TG synthesis [3]. Stearoyl-CoA desaturase 
1 (SCD1), which catalyzes the conversion of palmitate (C16:0) 
and stearate (C18:0) to palmitoleate (C16:1) and oleate (C18:1), 
respectively, is upregulated in obese humans and animals [4]. 
Moreover, the high ratio of monounsaturated to saturated fatty 
acid (C16:1/C16:0 and C18:1/C18:0) has been used as an index 
of obesity-related hyperlipidemia [5]. Therefore, measuring these 
lipogenesis- and lipolysis-related gene parameters and fatty acid 
composition will help elucidate the role of the liver in obesity 
development.
Several human studies have clearly shown that consumption 
of high levels of whole grain foods negatively correlates with 
a low incidence of obesity and related chronic diseases. Whole 
grains contain high fiber and essential nutrients, as well as 
phytochemicals such as polyphenols, sulfur compounds, and 
betaine [6]. Whole grains such as foxtail millet, hog millet, 
sorghum, Job’s tears, and barley have been used as ingredients 
in traditional Korean food. In a preliminary study by our group, 
hog millet (Panicum miliaceum L.) extract showed the highest 
anti-adipogenic activity by effectively inhibiting lipid synthesis, 
as measured by lipid-detecting Oil Red O staining, among extracts 
of nine types of cereal grains in a 3T3-L1 cell system [7]. 
In this study, we hypothesized that adding P. miliaceum L. 
extract (PME) to food would lead to weight loss and a decreased 
incidence of hyperlipidemia by regulating fatty acid metabolism. 
To test this hypothesis, we examined the effects of PME 
consumption on changes in obesity-related biomarkers, hepatic 
fatty acid metabolism-related gene expression, and white adipose 
tissue (WAT) fatty acid composition in normally obese C57BL/ 
6J-ob/ob  mice. The results confirmed the hypothesis. 
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Ingredients Control PME 0.5% PME 1%
Casein 200 200 200
Corn starch 529.5 524.5 519.5
Sucrose 100 100 100
Soybean oil 70 70 70
Cellulose 50 50 50
Mineral mix
1) 35 35 35
Vitamin mix
2) 10 10 10
L-Cysteine 3 3 3
Choline bitartrate 2.5 2.5 2.5
t-BHQ
3) 0.014 0.014 0.014
PME
c 05 1 0
1) Diets were prepared according to AIN-93G diet [8] and the total value was 1,000 g.
2) Mineral mixture and vitamin mixture were prepared based on the AIN-93G diet [8].
3) t-BHQ,  tert-butylhydroquinone;  PME,  Panicum  miliaceum  L.  extract
Table 1. Composition of the experimental diets
a (g)
Materials and Methods
Preparation of P. miliaceum L. extract
P. miliaceum L. was obtained from the National Agricultural 
Cooperative Federation (Shinlim, Wonju, Korea). The millet was 
ground into fine powder (50 g), which was ultrasonically 
extracted twice with 500 mL hot water for 3 h at room 
temperature. The preliminary extract was then concentrated at 
80℃ in a rotator vacuum evaporator (EYELA N-1000, Tokyo 
Riakikai Co. Ltd., Japan). The final extract was subsequently 
freeze-dried and stored at -70℃. PME yield was 5.3%.
Animals and study design
Male leptin-deficient (C57BL/6J-ob/ob) mice and their counterpart 
C57BL/6J lean mice controls were purchased at 5 weeks of age 
from Jung-Ang Lab Animal Inc. (Seoul, Korea). The mice were 
housed two per cage in air-conditioned quarters with 12-h 
light/dark cycles. The animals were acclimated to the laboratory 
environment for 2 weeks and were then divided into four groups 
(n = 10 per group) based on their body weights: two groups (lean 
and  ob/ob control groups) were fed the AIN-93G control diet 
[8], and two groups were fed the PME-supplemented AIN-93G 
diets (0.5% and 1.0%, respectively). The respective composition 
of the experimental diets is shown in Table 1. After 4 weeks, 
the mice were anesthetized with light ether, and blood and tissues 
(liver and white adipose tissue) were collected. During the 
experimental period, animals had free access to water and food, 
and their body weights and food intake were measured twice 
weekly. The experimental design was approved by the National 
Academy of Agricultural Science, RDA (Approved No. NAAS 1003).
Preparation of blood and tissue samples
Serum was separated by centrifuging whole blood at 2,000 ×
g for 20 min and stored at -70℃ until assay. Liver and WAT 
(epididymal and peripheral WAT) were rinsed, weighed, frozen 
on dry ice, and stored at -70℃.
Blood lipid assays
Serum TG, total cholesterol (T-CHO), and high-density lipoprotein 
cholesterol (HDL) were determined using commercial assay kits 
(Asan Pharm., Seoul, Korea) according to the manufacturer’s 
protocols. 
Intraperitoneal glucose tolerance test
At the end of the 4-week diet protocol, an intraperitoneal 
glucose tolerance test (IGTT) was performed without anesthesia 
after an overnight (16 h) fast. Mice were fasted overnight to 
establish baseline glucose levels at time zero (0 min). Mice were 
weighed and then received an intraperitoneal injection of 2 g 
glucose/kg body weight. Subsequent blood samples were taken 
from the tail at 0, 30, 60, and 120 min after the glucose injection. 
Serum glucose was measured using an OneTouch Ultra Glucose 
Analyzer (LifeScan, Inc., Milpitas, CA, USA). Areas under the 
curve (AUCs) obtained from glucose measurements during the 
IGTT were used to reflect whole body glucose tolerance in this 
study.
Hematoxylin and eosin staining of liver and WAT sections
Mice livers and WAT tissues were fixed in 10% buffered 
formalin solution immediately after harvest. The tissues were 
then dehydrated in ethanol, embedded in paraffin wax, sectioned, 
and stained with hematoxylin and eosin. 
Serum insulin and inflammatory cytokine measurements 
Serum insulin was measured with an enzyme-linked immuno-
sorbent assay (ELISA) kit according to the manufacturer’s 
protocol (Millipore, Corp., Billerica, MA, USA). Serum tumor 
necrosis-α (TNF-α), interleukin-6 (IL-6), and monocyte chemo-
tactic protein-1 (MCP-1) were measured using ELISA kits (R&D 
Systems, Inc., Minneapolis, MN, USA) according to the manufa-
cturer’s protocol.
Fatty acid analysis
The fatty acid composition of WAT was analyzed using the 
method of Roberts et al. [9]. For fatty acid analysis, the lipid 
layer was obtained from the RNA isolation step. Methyl esters 
of total fatty acids were obtained by a reaction on a Techne 
DB-3D heating block (Barloworld Scientific US Ltd., Burlington, 
NJ, USA) using BF3 as a catalyst. A 20 mg aliquot of the oil 
sample was boiled with 2 mL methanolic sodium hydroxide (0.5 
M) at 100℃ for 5 min on the heating block. The BF3 reagent 
(2 mL) was added and boiled for an additional 5 min. Hexane Mi-Young Park et al. 513
Gene Primer sequences GenBank
TM No.
PPARα 5'-ATC CAC GAA GCC TAC C-3'
5'-CAC ACC GTA CTT TAG CAA G-3'
NM_011144
CPT1 5'-CCA GGC TAC AGT GGG ACA TT-3'
5'-GAA CTT GCC CAT GTC CTT GT-3'
NM_013495
L-FABP 5'-TGG ACC CAA AGT GGT CCG CA-3'
5'-AGT TCA GTC ACG GAC TTT AT-3'
NM_017399
FAS 5'-GGT CGT TTC TCC ATT AAA TTC TCA T-3'
5'-CTA GAA ACT TTC CCA GAA ATC TTC C-3'
NM_007988
SCD1 5'-TCG CCC CTA CGA CAA GAA CA-3'
5'-CCG GTC GTA AGC CAG GCC CA-3'
NM_009127
UCP2 5'-CAG AGC ACT GTC GAA GCC TA-3'
5'-GTA TCT TTG ATG AGG TCA TA-3'
NM_011671
PPARα, peroxisome proliferator-activated receptor; CPT1, carnitine palmitoyltrans-
ferase 1; L-FABP, liver-fatty acid binding protein; FAS, fatty acid synthase; SCD1, 
stearoyl-CoA  desaturase  1;  UCP2,  uncoupling  protein  2
Table 2. Primer sequences used for real-time PCR
Lean ob/ob ob/ob + 0.5% 
PME
ob/ob + 1% 
PME
Liver 
weight (g)
1.09 ± 0.12
c 3.63 ± 0.41
a 3.42 ± 0.67
a 2.74 ± 0.35
b
WAT 
weight (g)
0.28 ± 0.06
c 4.13 ± 0.52
a 3.94 ± 0.46
ab 3.21 ± 0.35
b
TG 
(mg/dL)
78.35 ± 3.94
c 142.84 ± 9.52
a 135.20 ± 12.83
a 114.98 ± 13.94
b
T-CHO 
(mg/dL)
120.35 ± 20.18
c 200.47 ± 18.96
a 188.06 ± 17.50
a 167.96 ± 12.98
b
HDL-C 
(mg/dL)
100.19 ± 10.46
ab 93.41 ± 7.45
b 115.28 ± 17.97
a 117.62 ± 9.87
a
1) V a lu e s  a r e  m e a n s±S D  ( n=1 0 ) .  V a lu e s  w it h in  a  r o w  w it h  d i f f e r e n t  letters  are 
significantly  different  from  each  other  at  P < 0.05  as  determined  by  Duncan’s 
multiple-range  test.
WAT, white adipose tissue; T-CHO, total cholesterol; TG, total triglyceride; HDL-C, 
high  density  lipoprotein-cholesterol 
Table 3. Tissues weights and serum parameters in lean and obese mice fed 
the 0.5% or 1% Panicum miliaceum L. extract (PME) diet for 4 weeks
1)
Fig. 1. Body weight changes in C57BL/6J and C57BL/6J-ob/ob mice fed the 
0.5% or 1% Panicum miliaceum L. extract (PME) diet. Values are means ± SD 
(n = 10).  * P < 0 . 0 5  v s .  t h e  o b e s e  c o n t r o l  g r o u p .
(1 mL) and a saturated sodium chloride solution (2 mL) was 
added and vortexed for 1 min. The hexane layer was transferred 
to a vial for subsequent gas chromatography analysis. Fatty acid 
methyl esters were identified by gas chromatography (Varian, 
CP-3800 GC, Australia) equipped with a flame ionization detector 
(FID) and an HP-FFAP capillary column (30 m × 0.32 mm I.D.
× 0.25 µm film thickness; Agilent Technologies, Santa Clara, 
CA, USA). The injector temperature was 230℃ with a split ratio 
of 10:1; the FID temperature was 250℃. The oven temperature 
ran a program of 100℃ for 1 min, followed by an incremental 
temperature increase from 100℃ to 230℃ at a rate of 3℃ per 
minute, and finally a 230℃ step for 10 min. Helium was used 
as the carrier gas with a constant flow rate of 1.0 mL/min and 
injection volume was 1 µL. The hydrogen flow rate to the 
detector was 40 mL/min, the air flow rate was 300 mL/min, and 
the helium make-up gas flow rate was 20 mL/min. 
RNA isolation and real-time reverse transcription polymerase 
chain reaction (RT-PCR)
Total RNA was isolated from mouse liver tissues using Trizol 
reagent (Invitrogen, Carlsbad, CA, USA) following the manufac-
turer’s recommendations. Real-time quantitative PCR was 
performed with a SYBR Green kit (Quantitect
TM SYBR Green 
PCR, Qiagen, Valencia, CA, USA). The cycling conditions were 
15 min at 95℃, followed by 40 cycles of 15 s at 94℃, 30 s 
at 45℃, and 30 s at 72℃. Melting curves were analyzed for 
each reaction, and each primer set was determined to produce 
a single PCR product. Relative quantification was calculated 
using the delta-delta Ct (cycle threshold) method [10]. The 
sequences of the primers for the genes examined are shown in 
Table 2. 
Statistical analysis
Data are expressed as mean ± standard deviation. Data were 
analyzed by a one-way analysis of variance followed by Duncan’s 
multiple range tests. A P-value < 0.05 was considered statistically 
significant.
Results 
1% PME-supplemented diet suppressed weight gain and WAT 
accumulation in obese ob/ob mice
Based on our previous study showing that PME inhibited fatty 
acid synthesis in vitro, we hypothesized that PME in the diet 
might inhibit weight gain in vivo. To determine whether a 
PME-supplemented diet could reduce weight gain in obese ob/ob 
mice, we fed these animals a diet supplemented with 1% PME 
and monitored weight gain as well as epididymal and peripheral 
WAT accumulation. At the onset of the study, the ob/ob mice 
weighed 48.39% more than their counterpart lean mice (Fig. 1, 
P < 0.05). Starting at week 4, the average body weight gain of 
mice fed the 1% PME diet was lower than the weight gain noted 
in the control ob/ob mice, however, no significant difference was 
observed in the 0.5% PME diet group (Fig. 1, P < 0.05). The 
liver and WAT weights of mice fed the 1% PME diet were 
significantly lower by 24.52% and 22.28%, respectively, compared 514 Anti-lipogenic activity of Panicum miliaceum L.)
(A)
(B)
Fig. 2. Blood glucose levels obtained during the intraperitoneal glucose 
tolerance test (IGTT). (A) Percent area under the curve (AUC) (B) and insulin level 
(C) after the IGTT (2 g/kg) in C57BL/6J and C57BL/6J-ob/ob mice fed the 0.5% 
or 1% Panicum miliaceum L. extract (PME) diet. The C57BL/6J-ob/ob mice were 
fed the PME-supplemented diets for 4 weeks, and then the IGTT was performed. 
White and black bars represent the lean (C57BL/6J) and obese (C57BL/6J-ob/ob) 
control mice, respectively. Each bar represents the mean ± SD (n = 10). Bars with 
different  letters  differ  significantly  (P < 0.05)  from  each  other. 
Fig. 3. Blood insulin levels in lean and obese mice fed the 0.5% or 1% Panicum 
miliaceum L. extract (PME) diet. The  C57BL/6J-ob/ob  mice  were  fed  the 
PME-supplemented diets for 4 weeks. Values are means ± SDs (n = 10). Bars with 
different  letters  differ  significantly  (P < 0.05)  from  each  other.
to those in obese ob/ob control mice (Table 3, P < 0.05). This 
result indicated that PME was able to inhibit weight gain and 
WAT accumulation experienced by obese ob/ob mice on a 
normal diet.
Obesity-induced hyperglycemia and hyperinsulinemia decreased 
in ob/ob mice fed a 1% PME-supplemented diet
Because we observed that PME inhibited weight gain, we next 
determined whether PME could also inhibit the hyperglycemia 
and high insulin levels associated with obesity in obese ob/ob 
mice. Therefore, we conducted an IGTT assessment after 4 weeks 
of PME treatment. The basal fasting blood glucose level in the 
control lean mice was 65.1 ± 3.5 mg/dL compared to 168.17 ± 
30.36 mg/dL in the control ob/ob mice on the normal diet, 
indicating severe hyperglycemia in the ob/ob mice. We found 
that PME treatment significantly lowered mean plasma glucose 
concentrations at 120 min after glucose administration (2 g/kg 
BW) compared with those in the ob/ob control mice on a normal 
diet (Fig. 2A, P < 0.05). The AUC for glucose in mice fed the 
1% PME diet also showed a decrease of 18.19% compared to 
that in the ob/ob control mice (Fig. 2B, P < 0.05). These data 
indicate improved glucose tolerance in the obese mice fed the 
1% PME diet. Serum insulin concentrations in mice decreased 
by 13.13% compared to those in ob/ob control mice (Fig. 3, P
< 0.05). Taken together, these data indicate that feeding ob/ob 
mice the 1% PME diet improved glucose tolerance and 
hyperinsulinemia compared to those in mice fed the normal diet. 
PME diet decreased obesity-associated blood lipid levels
To determine whether the PME-supplemented diet could 
regulate lipid levels in the blood, we measured TG, T-CHO, and 
HDL in ob/ob mice fed PME as compared to the normal diet. 
As compared to lean C57BL/6J mice, the obese ob/ob control 
mice exhibited higher concentrations of both TG and T-CHO 
but lower concentrations of HDL (Table 3, P< 0.05), as expected 
from previous studies. However, treatment with the 1% PME 
diet reduced the levels of serum TG and T-CHO by 19.50% and 
16.22%, respectively, compared to those in the obese ob/ob 
control mice (Table 3, P < 0.05). The 1% PME diet was also 
able to increase HDL concentration by 25.92% compared to that 
in the ob/ob control mice (Table 3, P < 0.05). These results 
indicate that PME reduced the levels of obesity-associated lipids 
released into the blood.
PME-supplemented diet reduces tissue lipid accumulation in liver 
and WAT
Because we observed lower levels of obesity-associated lipids 
in the bloodstream of ob/ob mice treated with 1% PME- 
supplemented diet, we wondered whether that would translate 
into decreased lipid accumulation in the liver and WAT. Thus, 
the lipid accumulation in the liver and WAT of mice was 
observed by optical microscopy (Fig. 4). The livers of the 
C57BL/6J-ob/ob mice on a normal diet had numerous lipid 
droplets as compared to those in the lean mice (C57BL/6J) 
controls. In contrast, smaller and fewer lipid droplets were present 
in the liver sections from PME-fed ob/ob mice (Fig. 4A-D) than Mi-Young Park et al. 515
(A) (B) (C) (D) 
C57BL/6J C57BL/6J-ob/ob  
  
C57BL/6J-ob/ob + 0.5% PME C57BL/6J-ob/ob + 1% PME
(E) (F) (G) (H)
C57BL/6J C57BL/6J-ob/ob
  
C57BL/6J-ob/ob + 0.5% PME C57BL/6J-ob/ob + 1% PME
(I)
Fig. 4. Microphotographs of the liver and white adipose tissue (WAT) in lean and obese mice fed the 0.5% or 1% Panicum miliaceum L. extract (PME) diet. The 
C57BL/6J-ob/ob mice were fed the PME-supplemented diets for 4 weeks. After 4 weeks, liver and WAT sections were stained with hematoxylin and eosin and observed 
by microscopy using a 200 × objective. Representative images of the liver (A-D), adipose tissue (E-H), and relative adipocyte size (I). (A, E) C57BL/6J, (B, F) C57BL/6J-ob/ob, 
(C, G) C57BL/6J-ob/ob +0.5% PME diet, (D, H) C57BL/6J-ob/ob + 1.0% PME diet. Values are means ± SDs (n = 10). Bars with different letters differ significantly (P < 0.05) 
from  each  other.
Fatty acid content (%) Lean ob/ob ob/ob + 0.5% PME ob/ob + 1% PME
Palmitic a. (C16:0) 20.43 ± 0.12
c 23.72 ± 0.15
a 23.44 ± 0.07
ab 22.75 ± 0.04
b
Palmitoleic a. (C16:1) 6.57 ± 0.36
c 9.95 ± 0.75
a 9.78 ± 0.51
ab 8.54 ± 0.42
b
Stearic a. (C18:0) 2.11 ± 0.61
a 2.05 ± 0.17
a 2.21 ± 0.12
a 2.30 ± 0.16
a
Oleic a. (C18:1) 36.19 ± 0.77
c 43.21 ± 0.98
a 42.95 ± 1.47
ab 41.11 ± 0.40
b
C16:1/C16:0 ratio 0.32 ± 0.14
b 0.43 ± 0.21
a 0.43 ± 0.25
a 0.38 ± 0.13
a
C18:1/C18:0 ratio 17.15 ± 0.33
c 21.08 ± 0.34
a 19.43 ± 2.27
ab 17.87 ± 0.24
b
1) Values are means±SD (n=4). Values within a row with different letters are significantly different from each other at P < 0.05, as determined by Duncan’s multiple-range 
test.
Palmitic  a.,  palmitic  acid;  Palmitoleic  a.,  palmitoleic  acid;  Stearic  a.,  stearic  acid;  Oleic  a.,  oleic  acid
Table 4. Fatty acid composition and the 18:1/18:0 white adipose tissue (WAT) ratio in obese mice fed the 0.5% or 1% Panicum miliaceum L. extract (PME) diet
for 4 weeks
1)
those in the control mice. Moreover, the size of the adipocytes 
in the WAT of mice fed the 1% PME diet was smaller than 
that in the ob/ob control group (Fig. 4E-I). These results indicate 
that hypertrophy of adipocytes decreased in the PME groups, 
and that the PME-induced reduction in fat mass was partly due 
to a decrease in adipocyte size.
PME-supplemented diet inhibited the synthesis of obesity-related 
monounsaturated fatty acids in WAT
The fatty acid desaturation index (C16:1/C16:0 and C18:1/C18:0) 
increases in adipose tissue of obese rat models [11]. We 
determined whether the PME diet could decrease the relative 516 Anti-lipogenic activity of Panicum miliaceum L.)
(A)
(B)
(C)
Fig. 5. Serum inflammatory mediators in lean and obese mice fed the 0.5% 
or 1% Panicum miliaceum L. extract (PME) diet. The C57BL/6J-ob/ob mice 
were fed the PME-supplemented diets for 4 weeks. After  4  weeks,  tumor 
necrosis  factor  (TNF)-α,  interleukin  (IL)-6,  and  monocyte  chemotactic  protein-1 
(MCP-1) levels were measured. White and black bars represent the lean (C57BL/6J) 
and obese (C57BL/6J-ob/ob) control mice, respectively. A, Serum TNF-α levels; 
B, Serum IL-6 levels; C, Serum MCP-1 levels. Each bar represents the mean ±
SD (n = 10). Bars with different letters differ significantly (P<0.05) from each other.
Lean ob/ob ob/ob + 0.5% PME ob/ob + 1% PME
PPARα 0.62 ± 0.09
b 1.00 ± 0.15
a 0.86 ± 0.12
a 0.76 ± 0.06
b
CPT1 1.46 ± 0.19
a 1.00 ± 0.07
b 1.12 ± 0.08
ab 1.36 ± 0.05
a
L-FABP 0.52 ± 0.09
b 1.00 ± 0.08
a 0.97 ± 0.12
a 0.88 ± 0.03
b
FAS 0.59 ± 0.05
c 1.00 ± 0.09
a 0.90 ± 0.25
ab 0.78 ± 0.04
b
SCD1 0.47 ± 0.03
c 1.00 ± 0.12
a 0.85 ± 0.09
ab 0.75 ± 0.03
b
UCP2 0.66 ± 0.06
c 1.00 ± 0.20
a 0.82 ± 0.12
ab 0.79 ± 0.04
b
1) Values  are  means ± SD  (n = 10).  Values  within  a  row  with  different  letters  are 
significantly different from each other at P < 0.05, as determined by Duncan’s
multiple-range  test.
PPARα, peroxisome proliferator-activated receptor; CPT1, carnitine palmitoyltrans-
ferases 1; L-FABP, liver-fatty acid binding protein; FAS, fatty acid synthase; SCD1, 
stearoyl-CoA  desaturase  1;  UCP2,  uncoupling  protein  2
Table 5. Relative mRNA expression in livers from lean and obese mice fed the
0.5% or 1% Panicum miliaceum L. extract (PME) diet for 4 weeks
1)
amount of saturated fatty acids that accumulate in WAT, which 
are associated with obesity. We found that the 1% PME diet 
significantly decreased the levels of palmitoleic acid (C16:1) and 
oleic acid (C18:1). This was then reflected in a decrease in the 
desaturation index (Table 4). The 18:1/18:0 ratio was reduced 
by 15.23% in the 1% PME diet group mice compared to that 
in the ob/ob control mice (Table 4, P < 0.05). Palmitic acid 
(C16:0) is produced during monounsaturated fatty acids synthesis; 
both stearic acid (C18:0) and oleic acid (C18:1) are potential 
end products of palmitic acid (C16:0) synthesis [9]. Our data 
also showed that both palmitic acid (C16:0) and oleic acid 
(C18:1) contents decreased effectively by the 1% PME diet 
compared to those in the ob/ob control mice (Table 4, P< 0.05). 
These data indicate that the PME diet effectively downregulated 
monounsaturated fatty acid synthesis, thereby inhibiting a major 
step in the lipogenesis process.
Lipogenic and lipolytic genes in the liver were altered by the 
PME-supplemented diet 
We determined the hepatic expression of genes involved in 
lipogenesis and lipolysis to determine whether the expression of 
lipogenic and lipolytic genes involved in fatty acid synthesis were 
altered in the livers of mice treated with PME. We found that 
the lipogenic genes, peroxisome proliferator-activated receptor 
α (PPARα), liver-fatty acid binding protein (L-FABP), SCD1, 
and fatty acid synthase (FAS), decreased significantly in mice 
fed the 1% PME diet compared to those in the obese ob/ob 
control mice (Table 5, P < 0.05). Collectively, these genes 
promote de novo monounsaturated fatty acid synthesis. Therefore, 
these data indicate that PME is involved in regulating genes that 
dampen the synthesis of fatty acids by inhibiting these lipogenic 
genes. In contrast, the lipolytic gene carnitine palmitoyltransferase 
1 (CPT1), a key enzyme in the mitochondrial beta-oxidation of 
fatty acids, increased significantly by 36.24% in the mice fed 
the 1% PME diet compared to that in the ob/ob control mice, 
indicating that PME promotes genes involved in fatty acid 
metabolism (Table 5, P < 0.05). Furthermore, we found that the 
mRNA expression of uncoupling protein 2 (UCP2), which is 
involved in the mitochondrial energy balance and whose hepatic 
expression is increased in ob/ob mice [12], was effectively 
downregulated by the 1% PME diet compared to that in the ob/ob 
control mice (Table 5, P< 0.05). Taken together, these data show 
that consuming a diet supplemented with PME could inhibit fatty 
acid synthesis but enhance fatty acid oxidation in the liver tissue 
of ob/ob mice.Mi-Young Park et al. 517
PME diet inhibited the production of obesity-associated pro- 
inflammatory cytokines and chemokines in serum
We measured serum MCP-1, TNF-α, and IL-6 levels to investigate 
whether supplementing the diet with 1% PME can modulate 
obesity-related inflammation. MCP-1 is an important chemokine 
for macrophage infiltration into adipose tissue, and tumor TNF-α 
and IL-6 are representative cytokines involved with obesity- 
related inflammation. As shown in Fig. 4, mice fed the 1% PME 
diet had significantly decreased serum levels of MCP-1, TNF-α, 
and IL-6, by 19.50%, 24.46%, and 24.52%, respectively, compared 
to those in ob/ob control mice (Fig. 5, P < 0.05). This result 
indicated that PME functions to inhibit the release of obesity- 
related pro-inflammatory cytokines.
Discussion
In this study, we investigated whether supplementing the diet 
with PME could control and reduce the weight gain observed 
in obese C57BL/6J-ob/ob mice. C57BL/6J-ob/ob mice have a 
point mutation in the leptin gene, which is a key weight control 
hormone. These leptin-deficient mice become grossly overweight 
at a young age and develop obesity-related disorders including 
hyperglycemia, hyperlipidemia, and hepatic lipid accumulation 
[13]. In this study, we demonstrated that the 1% PME- 
supplemented diet effectively inhibited lipid accumulation in the 
liver and ameliorated hyperlipidemia in C57BL/6J-ob/ob mice. 
This was the lowest effective dose, as no significant weight 
difference was observed in the lower dose 0.5% PME diet group. 
We examined the mRNA expression of lipogenesis and 
lipolytic genes in the liver to elucidate the mechanism behind 
the 1% PME suppression of weight gain. We showed that the 
1% PME diet decreased mRNA expression levels of L-FABP, 
PPARα, SCD1, and FAS lipogenic genes in the liver. L-FABP 
facilitates hepatic fatty acid uptake by incorporating long chain 
fatty acids into triacylglycerols during anabolic metabolism [14]. 
The transcription factor PPARα induces the expression of both 
fatty acid elongases (Elov-5 and Elov-6) and desaturases and 
facilitates monounsaturated fatty acid (C18:1) synthesis in 
C57BL/6J ob/ob mice [15]. SCD1, the rate-limiting enzyme in 
monounsaturated fatty acid biosynthesis, promotes the conversion 
of stearic acid (C18:0) to oleic acid (C18:1) during de novo 
lipogenesis [16]. Therefore, the elevated ratio of oleic (C18:1) 
to stearic acid (C18:0) observed in obese animals indicated that 
SCD activity must be high in these animals, and that 1% PME 
was able to inhibit this activity. Finally, FAS, a typical lipogenic 
enzyme, is upregulated in ob/ob mice [17,18], but its expression 
was inhibited by 1% PME. Interestingly, the levels of the fatty 
acids palmitic acid (C16:0), an end-product of monounsaturated 
fatty acid synthesis, and oleic acid (C18:1), a potential end- 
product of palmitic acid (C16:0), were also reduced in the 1% 
PME supplemented group compared to those in the obese ob/ob 
control group. This result correlated well with the down- 
regulation of hepatic L-FABP and PPARα mRNA expression. 
These data indicate that the PME diet decreased monounsaturated 
fatty acid synthesis by inhibiting fatty acid uptake and elongation- 
related gene expression. Moreover, both oleic acid (C18:1) 
content and the C18:1/C18:0 ratio in adipose tissue decreased 
significantly, and hepatic SCD1 and FAS mRNA expression were 
down-regulated in the 1% PME diet group compared those in 
the ob/ob control group. These results collectively suggest that 
the inhibitory effect of PME diet on hepatic lipogenic gene 
expression is one mechanism that PME uses to suppress lipid 
accumulation in the liver. 
We demonstrated that the 1% PME diet inhibited the 
expression of lipogenic genes in the liver and also revealed that 
this diet promoted the expression of lipolytic genes involved in 
metabolizing fatty acids. We showed that the liver CPT1 mRNA 
expression level was elevated in the 1% PME-treated ob/ob mice. 
CPT1 is a mitochondrial transmembrane enzyme and is a rate- 
limiting enzyme for long-chain fatty acid entry into the 
mitochondria for β-oxidation [19-21]. This observation is 
consistent with the role of PME suppressing weight gain and 
suggests that PME could effectively regulate fatty acid metabolism 
in the liver by promoting fatty acid β-oxidation. Additionally, 
these effects may have been associated with reduced serum TG 
and cholesterol levels as well as adipose tissue weight gain and 
hepatic lipid accumulation in ob/ob mice. 
An energy imbalance leads to obesity [22], and the liver plays 
a key role in the regulation of energy homeostasis [23]. UCP2 
is a key regulator of energy balance and is highly expressed in 
fatty and steatotic livers. Indeed, UCP2 mRNA overexpression 
in liver tissue contributes to the obesity-related vulnerability to 
endotoxin liver damage [24]. In this study, we found that the 
1% PME diet significantly inhibited the elevated hepatic UCP2 
mRNA expression level observed in ob/ob obese mice on a 
normal diet. This result indicates that the PME diet contributed 
to restoring the energy homeostatic balance in ob/ob mice. 
The mechanism underlying lipid accumulation in the body is 
partly associated with chronic low level inflammation, and 
elevated inflammation is a consistent feature of obese mice [25]. 
Chronic low level inflammation is characterized by activation 
of the nuclear factor-κB pathway and abnormal release of 
inflammatory factors including MCP-1, TNF-α, and IL-6. MCP-1 
is a key chemokine that induces macrophage infiltration into 
adipose tissue; these recruited macrophages then release pro- 
inflammatory cytokines including TNF-α and IL-6. Both TNF-α 
and IL-6 stimulate an increase in the concentration of blood free 
fatty acids, which eventually leads to an increase in hepatic 
lipogenesis and contributes to hepatic lipid accumulation and 
hyperlipidemia [26]. In this study, we showed that while serum 
MCP-1, TNF-α, and IL-6 levels were dramatically elevated in 
ob/ob mice on a normal diet compared to those in lean mice 
controls, the ob/ob mice on the 1% PME diet demonstrated 
significantly decreased serum levels of these inflammatory 518 Anti-lipogenic activity of Panicum miliaceum L.)
cytokines compared to those in obese ob/ob mice on a normal 
diet. We speculate that this might be a direct effect of PME 
on macrophages, because we showed in our previous study that 
PME effectively inhibits gene expression and release of pro- 
inflammatory mediators from lipopolysaccharide-induced macro-
phages, including MCP-1, TNF-α, and IL-6, by downregulating 
IL-1 receptor associated kinase-4 (IRAK-4) signaling [27]. 
Interestingly, Rekhter et al. [28] reported that IRAK4 deficiency 
is associated with an inhibition of macrophage infiltration and 
lipid accumulation in vascular lesions. Thus, our data support 
that PME modulates cytokine release; therefore, this effect of 
PME could be a mechanism to explain how PME inhibited 
hyperlipidemia and hepatic lipid accumulation. 
In summary, 1% PME-supplemented diet, but not 0.5%, 
ameliorated hyperlipidemia, hepatic lipid accumulation, and 
weight change in leptin-deficient C57BL/6J-ob/ob mice. Although 
the mediators actively responsible for the anti-obesity activity 
of PME were not identified in this study, our study showed that 
the beneficial effects of PME are related to the regulation of 
hepatic lipogenesis and lipolytic gene expression as well as an 
inhibition of cytokines and chemokine release. Overall, our study 
indicates that supplementing the diet with hog millet could be 
useful for treating obesity or obesity-related diseases and suggests 
a possible mechanism underlying how whole grains help to 
reduce obesity.
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